Omentectomy
Sponsors
Vanderbilt University Medical Center, Universidad de Guanajuato, NYU Langone Health, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Karolinska Institutet
Conditions
Age 18-64 YearsConfirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet TherapyDiabetes Mellitus Type 2Insulin SensitivityMetabolic SyndromeMorbid ObesityObesityPatients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2
Early Phase 1
Phase 2
Unknown Phase
The Role of the Omentum in the Treatment of Morbid Obesity
CompletedNCT00212160
Start: 2005-01-31End: 2011-10-31Updated: 2017-02-01
Omentectomy and Metabolic Syndrome
CompletedNCT00923260
Start: 2005-12-31End: 2008-07-31Updated: 2009-12-07
Effects of Different Surgical Methods to Treat Obesity
CompletedNCT01785134
Start: 2006-05-31End: 2011-12-31Updated: 2014-10-02